We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Industry Insights

Exploring Droplet Digital PCR Technology
Industry Insight

Recently, we interviewed George Karlin-Neumann, Clinical Director, Digital Biology Group at Bio-Rad Laboratories to learn more about ddPCR and its applications.

Read More

The Longitude Challenge - Developing a Diagnostic Test To Fight Antimicrobial Resistance
Industry Insight

We recently spoke with Daniel Berman, Global Health Lead at Nesta Challenges, to learn about the Longitude Prize, a £10 million prize fund with an £8 million pay-out, which will be awarded to a team that invents an affordable, accurate, fast and easy-to-use test for bacterial infections.

Read More

Exploring Cell Mechanics – From Ripe Avocados to Sepsis Diagnosis
Industry Insight

In this interview, Daniel Klaue explains why it is important to measure cell mechanics, discusses a novel method of doing so, and highlights how this technology could benefit clinical applications.

Read More

A Step Closer to a Bioengineered Liver Fit for Transplantation
Industry Insight

In a study recently published in Nature Biomedical Engineering, bioengineered livers created by decellularization and recellularization were implanted into pigs, where they were able to sustain continuous perfusion for up to 15 days. We spoke to Miromatrix’s CEO, Dr Jeff Ross, to learn more about the study and how it advances the state of bioengineering organs.

Read More

Collaboration Is the X Factor in Making Precision Medicine a Success
Industry Insight

Companion diagnostics (CDx), i.e. in vitro medical devices, and next-generation sequencing (NGS), are both essential to the practice of precision medicine. As new regulations are introduced, pharma companies and manufacturers alike need to ensure their CDx processes are compliant or we could see a deceleration in the flow of new precision therapies in the near future.

Read More

Synthesis Innovation in Drug Discovery
Industry Insight

We recently had the pleasure of speaking with Danica Rankic, Associate Principal Scientist, MSD to learn more about their process chemistry activities. She touches on the synthesis strategies impacting drug discovery and provides a snapshot of her upcoming talk, taking place December, 2019.

Read More

Next-generation Sequencing Advancements in the Diagnostic Lab
Industry Insight

Agilent are working to increase the utility of NGS in the diagnostics field and in personalized medicine. We recently spoke with Ronda Allen, Head of R&D at Agilent, to learn more about two of Agilent's newest products in this space, the Cancer All-in-one (AIO) panels, and the Magnis NGS Library Prep System.

Read More

Speed, Sensitivity, and High-throughput Analysis: The Latest Advancements in Metabolomics
Industry Insight

To find out more about the recent advances in metabolomics and the technologies that have evolved alongside it, we spoke with Lucy Woods, Global Technology Leader at Bruker Daltonics.

Read More

Fuelling Innovation in UK Life Sciences
Industry Insight

We spoke to Daniel Rooke, Head of Operations and Legal at Start Codon, to learn more about the company and how they can help early stage healthcare and life science businesses in the UK to get off the ground.

Read More

Therapeutically Targeting the Interconnected Biology of the Gut
Industry Insight

We recently had the pleasure of interviewing Paul-Peter Tak, CEO of Kintai Therapeutics. Tak discusses how Kintai Therapeutics are exploiting the power of big data and machine learning to unravel the interconnected biology of the gut, and explains how the enteric signaling network can be therapeutically targeted.

Read More

 
Advertisement